EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The pros and cons of lung cancer screening

Roberta Eufrasia Ledda, Georg-Christian Funk, Nicola Sverzellati

European Radiology · 16.07.2024 · 35 (1) · 267-275

DOI: 10.1007/s00330-024-10939-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Radiology, online erschienen am 16.07.2024. Verfasst von Roberta Eufrasia Ledda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy. robertaeufrasia.ledda@unipr.it. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer, Tomography, X-Ray Computed. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several trials have shown that low-dose computed tomography-based lung cancer screening (LCS) allows a substantial reduction in lung cancer-related mortality, carrying the potential for other clinical benefits. There are, however, some uncertainties to be clarified and several aspects to be implemented to optimize advantages and minimize the potential harms of LCS. This review summarizes current evidence on LCS, discussing some of the well-established and potential benefits, including lung cancer (LC)-related mortality reduction and opportunity for smoking cessation interventions, as well as the disadvantages of LCS, such as overdiagnosis and overtreatment. Clinical relevance statement Different perspectives are provided on LCS based on the updated literature. Key Points Lung cancer is a leading cancer-related cause of death and screening should reduce associated mortality . This review summarizes current evidence related to LCS . Several aspects need to be implemented to optimize benefits and minimize potential drawbacks of LCS .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsEarly Detection of CancerTomography, X-Ray ComputedHumansMass ScreeningSmoking CessationMedical Overuse

Stichwörter der Autor:innen

Benefits and harmsLow-dose computed tomographyLung cancer screening

Autor:innen und Institutionen

  • Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy. robertaeufrasia.ledda@unipr.it.
  • Department of Medicine II with Pneumology, Karl Landsteiner Institute for Lung Research and Pulmonary Oncology, Klinik Ottakring, Vienna, Austria.
  • Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy.

Zitieren

APA

Ledda, R. E., Funk, G. C., & Sverzellati, N. (2024). The pros and cons of lung cancer screening. European Radiology, 35(1), 267-275. https://doi.org/10.1007/s00330-024-10939-6

Vancouver

Ledda RE, Funk GC, Sverzellati N. The pros and cons of lung cancer screening. European Radiology. 2024;35(1):267-275. doi:10.1007/s00330-024-10939-6

BibTeX
@article{Ledda2024,
  author = {Ledda, Roberta Eufrasia and Funk, Georg-Christian and Sverzellati, Nicola},
  title = {The pros and cons of lung cancer screening},
  journal = {European Radiology},
  year = {2024},
  volume = {35},
  number = {1},
  pages = {267--275},
  doi = {10.1007/s00330-024-10939-6}
}
Kostenlos starten →